A multinational team led by Weill Cornell Medicine investigators developed a test for an HIV strain that disproportionately affects women and will benefit patients around the world.
ACT for Youth, which promotes adolescent health and well-being in New York state, has been awarded $5 million to help local health departments improve care for youth with special needs.
Before a cell commits fully to the process of dividing itself into two new cells, it may ensure the appropriateness of its commitment by staying for many hours – sometimes more than a day – in a reversible intermediate state, according to new research.
Michael I. Kotlikoff assumes the role of Cornell’s interim president following the retirement of Cornell’s 14th president, Martha E. Pollack. He will serve until 2026.
A study involving more than 3.6 million people who’d already received COVID vaccinations found that offering free Lyft rides to a vaccination site was no more enticing than simply reminding people of the importance of getting boosted.
Weill Cornell Medicine received a $1.5 million grant to develop new approaches for predicting the spread of cancer cells to the bone in men with prostate cancer, using tumor samples taken at early stages of the disease.
The inaugural Inclusion and Belonging Summit was held on June 12, 2024 and hosted at Weill Cornell Medicine, drawing nearly 40 employees from Cornell’s main campus in Ithaca, Cornell Tech, Weill Cornell Medicine and other higher education institutions to New York City.
The transition to menopause is marked by a progressively higher density of estrogen receptors on brain cells, a measure that remains elevated in women up to their mid-60s, according to a new brain imaging study.
An artificial intelligence-powered method for detecting tumor DNA in blood has the potential to improve cancer care with the very early detection of recurrence and close monitoring of tumor response during therapy.
